Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

C1orf181 Activators

C1orf181 Activators would ostensibly pertain to a specialized class of chemical agents designed to modulate the activity of the protein product encoded by the human gene C1orf181. The "C1orf" prefix indicates that this gene is situated on chromosome 1 and is described as an open reading frame, which suggests that the gene is recognized as a protein-coding sequence.Such activators would be characterized by their ability to increase the biological activity of the C1orf181 protein. The activation could be achieved by direct interaction with the protein, potentially altering its structure, dynamics, or interactions with other cellular components, thereby enhancing its natural function within the cell. The chemical nature of these activators could encompass a wide range of molecules, from small organic compounds to larger macromolecules, each designed to affect the C1orf181 protein's activity through precise molecular interactions.

In the exploration of C1orf181 activators, researchers would likely undertake a comprehensive suite of experimental procedures to identify and characterize potential activating compounds. Utilizing in vitro assay systems, scientists could measure the impact of candidate molecules on the activity levels of the C1orf181 protein. These assays would provide initial insights into the potency and specificity of the interactions. Further investigations might involve structural biology techniques such as X-ray crystallography or cryo-electron microscopy, which would help to elucidate the molecular basis of the interaction between the activators and the C1orf181 protein. Such structural data would be critical for understanding how these compounds bind to the protein, potentially revealing allosteric sites or other regulatory regions that are key to the protein's activation. Despite the potential for scientific inquiry, it is important to recognize that the concept of C1orf181 activators is, at present, purely speculative, and there exists no established body of research that identifies or characterizes such a class of chemicals.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

This compound is a DNA methyltransferase inhibitor, potentially leading to demethylation and activation of gene expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

As an HDAC inhibitor, vorinostat can alter chromatin structure and increase transcription of various genes.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

This short-chain fatty acid also functions as an HDAC inhibitor, potentially affecting gene expression.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide and its derivatives modulate degradation of transcription factors, potentially affecting gene expression.

Cyclen

294-90-6sc-255035
250 mg
$128.00
(0)

This Notch signaling pathway inhibitor could alter gene transcription profiles, potentially affecting ZNHIT6 expression.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

Tamoxifen is a selective estrogen receptor modulator which can influence gene expression in hormone-responsive tissues.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR signaling, which is involved in the control of protein synthesis and may affect gene expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

This proteasome inhibitor can affect a variety of cellular pathways and potentially increase gene expression by affecting protein turnover.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium affects several signaling pathways, including GSK-3 inhibition, which can modulate gene expression.

Sulindac

38194-50-2sc-202823
sc-202823A
sc-202823B
1 g
5 g
10 g
$32.00
$86.00
$150.00
3
(1)

Sulindac, a nonsteroidal anti-inflammatory drug, can inhibit Wnt/β-catenin signaling, potentially affecting gene expression.